233 related articles for article (PubMed ID: 15462695)
1. The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary care.
Bramlage P; Pittrow D; Kirch W
Curr Med Res Opin; 2004 Oct; 20(10):1625-31. PubMed ID: 15462695
[TBL] [Abstract][Full Text] [Related]
2. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
Strutz F; Bramlage P; Paar WD
Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
Lewin AJ; Weir MR
Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
[TBL] [Abstract][Full Text] [Related]
5. BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.
Schrader J; Bramlage P; Lüders S; Thoenes M; Schirmer A; Paar DW
Clin Drug Investig; 2007; 27(11):783-96. PubMed ID: 17914897
[TBL] [Abstract][Full Text] [Related]
6. Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.
Ketelhut R; Bramlage P
Clin Drug Investig; 2010; 30(5):301-11. PubMed ID: 20384386
[TBL] [Abstract][Full Text] [Related]
7. [IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting].
Lehnert H; Bramlage P; Pittrow D; Kirch W
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():81-7. PubMed ID: 15490772
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
Neutel JM
Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
11. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
Chrysant SG; Neutel JM; Ferdinand KC;
J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
[TBL] [Abstract][Full Text] [Related]
12. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.
Croom KF; Curran MP; Goa KL; Perry CM
Drugs; 2004; 64(9):999-1028. PubMed ID: 15101793
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
Sowers JR; Neutel JM; Saunders E; Bakris GL; Cushman WC; Ferdinand KC; Ofili EO; Weber MA;
J Clin Hypertens (Greenwich); 2006 Jul; 8(7):470-80. PubMed ID: 16849900
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a fixed combination of irbesartan/hydrochlorothiazide in Chinese patients with moderate to severe hypertension.
Huang QF; Sheng CS; Li Y; Ma GS; Dai QY; Wang JG;
Drugs R D; 2013 Jun; 13(2):109-17. PubMed ID: 23605903
[TBL] [Abstract][Full Text] [Related]
15. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
Parving HH; Lehnert H; Bröchner-Mortensen J; Gomis R; Andersen S; Arner P;
N Engl J Med; 2001 Sep; 345(12):870-8. PubMed ID: 11565519
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.
Ofili EO; Cable G; Neutel JM; Saunders E
J Womens Health (Larchmt); 2008; 17(6):931-8. PubMed ID: 18681815
[TBL] [Abstract][Full Text] [Related]
17. Irbesartan effects on renal function in patients with renal impairment and hypertension: a drug-withdrawal study.
De Rosa ML; de Cristofaro A; Rossi M; Baiano A; Cardace P; Albanese L; Vigorito C
J Cardiovasc Pharmacol; 2001 Sep; 38(3):482-9. PubMed ID: 11486253
[TBL] [Abstract][Full Text] [Related]
18. [Observational study of blood pressure control and microalbuminuria in type 2 diabetics on irbesartan or irbesartan/HCTZ].
Schmieder RE; Krekler M
MMW Fortschr Med; 2005 Oct; 147 Suppl 3():97-101. PubMed ID: 16261944
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
Neutel JM; Saunders E; Bakris GL; Cushman WC; Ferdinand KC; Ofili EO; Sowers JR; Weber MA;
J Clin Hypertens (Greenwich); 2005 Oct; 7(10):578-86. PubMed ID: 16227760
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
